Acoustic neuroma

听神经瘤
  • 文章类型: Journal Article
    背景:前庭神经鞘瘤(VS)是前庭耳蜗神经的良性肿瘤,通常会导致严重的神经和功能损害。患者报告的结果,包括生活质量(QoL),对于了解VS及其治疗的整体影响至关重要。这项研究旨在将前庭神经鞘瘤生活质量指数(VSQOL)转化并在文化上适应德语,以扩大其与德语人群的相关性。
    方法:我们使用了定性方法,包括翻译和认知访谈,对10名接受VS手术的患者进行了访谈。翻译过程遵循TRAPD协议,以确保语言和概念的准确性。认知访谈评估了翻译问卷的可理解性和相关性。
    结果:翻译显示出显着的翻译之间的一致性,微小的差异通过协商一致解决。认知访谈提供了宝贵的见解,从而改善了项目措辞。与会者强调了关于医生转诊的额外项目的重要性,反映了美国和德国之间医疗保健系统的差异。
    结论:德国VSQOL为VS患者的QoL评估提供了一个综合工具,整合了以患者为中心的维度。正在进行验证研究,以确定其可靠性和有效性。
    BACKGROUND: Vestibular schwannomas (VSs) are benign tumors of the vestibulocochlear nerve that often cause significant neurological and functional impairment. Patient-reported outcomes, including quality of life (QoL), are essential for understanding the overall impact of VS and its treatment. This study aimed to translate and culturally adapt the Vestibular Schwannoma Quality of Life (VSQOL) Index into German to expand its relevance to German-speaking populations.
    METHODS: We used a qualitative approach including translation and cognitive interviews with 10 patients who underwent VS surgery. The translation process followed the TRAPD protocol to ensure linguistic and conceptual accuracy. Cognitive interviews assessed the comprehensibility and relevance of the translated questionnaire.
    RESULTS: The translation showed remarkable consistency between translators, with minor discrepancies resolved by consensus. Cognitive interviews provided valuable insights that led to refinements in item wording. Participants emphasized the importance of an additional item on physician referrals, reflecting differences in health care systems between the United States and Germany.
    CONCLUSIONS: The German VSQOL provides a comprehensive tool for assessing QoL in patients with VS that integrates patient-centered dimensions. A Validation study is underway to establish its reliability and validity.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:侧颅底(LSB)和中耳病变通常涉及面神经(FN),他们的治疗可能需要FN牺牲。无法识别的近端残端或完整的FN伴完整的FN麻痹的病例,需要与另一个运动神经进行FN吻合,以恢复对模仿肌肉组织的神经支配。中耳和LSB手术后面瘫患者的舌下神经-面神经吻合术(HFA)和咬-面神经吻合术的结果,进行了介绍和比较。
    方法:纳入中耳或LSB手术后通过舌下神经或咬肌转移吻合术恢复面神经的完全确定性面瘫的成年患者。根据HouseBrackmann分级系统(HB)对面神经功能进行分级。3个月时的面部功能结果,6个月,12个月,比较18个月和最后一次随访(超过18个月)。
    结果:153例LSB和中耳手术后出现面神经麻痹,其中HF85例(55.5%),MF68例(44.5%)。重建手术前FN麻痹的持续时间与更好的FN结果成反比。特别是具有III级HB(p=0.003)。当麻痹发作和手术复发之间的间隔为6个月或更短时,两种技术的HB评分均显着降低(MFp=0.0401;HFp=0.0022)。接受MF的患者在手术后3个月时FN功能显着改善(p=0.0078)。在最后一次随访中,63.6%恢复到III级HB,22.7%恢复到IV级。另一方面,在HF组中获得的第一个显著结果是在手术后6个月(p<0.0001).67.8%的患者在末次随访时发生HF后出现III级HB,28.8%为Ⅳ级。与HF相比,MF组手术后6个月的FN分级显着降低(p=0.0351)。这两种技术在后来的后续评估中具有统计学上相似的结果。
    MF与最初的优异结果相关,在3个月时表现出明显的面部恢复,与HF相比,手术后6个月的功能结局明显更好。尽管在这项研究中后来的结果没有显着差异,早期结果对于限制角膜暴露风险的持续时间具有重要作用.
    BACKGROUND: Lateral skull base (LSB) and middle ear pathologies often involve the facial nerve (FN), and their treatment may require FN sacrifice. Cases with unidentifiable proximal stump or intact FN with complete FN palsy, necessitate FN anastomosis with another motor nerve in order to restore innervation to the mimicking musculature. The results of hypoglossal-to-facial nerve anastomosis (HFA) and masseteric-facial nerve anastomosis in patients with facial paralysis after middle ear and LSB surgeries, are presented and compared.
    METHODS: Adult patients with total definitive facial paralysis after middle ear or LSB surgery undergoing facial nerve reanimation through hypoglossal or masseteric transfer anastomosis were enrolled. The facial nerve function was graded according to the House Brackmann grading system (HB). The facial function results at 3 months, 6 months, 12 months, 18 months and at the last follow up (more than 18 months) are compared.
    RESULTS: 153 cases of LSB and middle ear surgery presented postoperative facial palsy and underwent facial nerve reanimation surgery with HF in 85 patients (55.5%) and MF in 68 patients (44.5%). The duration of the FN palsy before reconstructive surgery was inversely associated to better FN results, in particular with having a grade III HB (p = 0.003). Both techniques had significantly lower HB scores when an interval between palsy onset and reanimation surgery was 6 months or less (MF p = 0.0401; HF p = 0.0022). Patients who underwent a MF presented significant improvement of the FN function at 3 months from surgery (p = 0.0078). At the last follow-up, 63.6% recovered to a grade III HB and 22.7% to a grade IV. On the other hand, the first significant results obtained in the HF group were at 6 months from surgery (p < 0.0001). 67.8% of patients had a grade III HB after a HF at the last follow-up, 28.8% a grade IV. FN grading at 6 months from surgery was significantly lower in the MF group compared to the HF (p = 0.0351). The two techniques had statistically similar results at later follow-up evaluations.
    UNASSIGNED: MF was associated to initial superior results, presenting significant facial recovery at 3 months, and significantly better functional outcomes at 6 months from surgery compared to HF. Although later results were not significantly different in this study, earlier results have an important role in order to limit the duration of risk of corneal exposure.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:在前庭神经鞘瘤(VS)显微手术中保持面神经功能,如果肿瘤紧密粘附在变薄的面神经上,一些人主张次全切除术(STR)。这项研究的目的是确定残余体积是否与进展有关,以及在STR期间是否应追求阈值残余体积以防止复发。这项研究的第二个目的是确定最后一次随访时面神经功能是否与切除程度(EOR)相关。
    方法:回顾性收集164例VS患者的临床和影像学资料。使用Visage测量肿瘤体积,并采用标准统计学方法。使用House-Brackmann量表评估手术前和末次随访时面神经功能的变化。
    结果:61例患者(37%)接受了全切除(GTR),103例(63%)接受了STR。中位临床和影像学随访时间分别为49和48个月,分别。STR后的中值残余体积为0.5cm3。Kaplan-Meier精算生存分析显示GTR后5年无进展生存率(PFS)为96.3%,高于STR后的水平(84.5%,p=0.03)。接受STR的患者的递归分区分析显示,0.60cm3的残余体积是复发的最佳阈值。残余体积≥0.60cm3的患者5年PFS为76.0%,无论佐剂SRS,低于接受GTR(96.3%)或STR(95.6%)且残留体积<0.60cm3(p<0.01)的患者。关于Cox回归分析,残余体积≥0.60cm3(HR14.4,p=0.01)与进展独立相关,即使考虑到患者年龄,辅助放射外科,和术前肿瘤大小。在最后一次治疗后至少24个月随访的112例患者中,在中位末次随访71个月时,111例(99.1%)患者实现了肿瘤控制.末次随访时更差的面神经功能与VS的先前治疗独立相关(校正OR3.7,p=0.04),但不是残余体积队列或术前肿瘤体积。
    结论:VS切除后剩余体积>0.60cm3与肿瘤进展独立相关,甚至考虑辅助SRS。这些数据支持在VS手术过程中最大化EOR,即使GTR不能安全实现。
    OBJECTIVE: To preserve facial nerve function in vestibular schwannoma (VS) microsurgery, some have advocated subtotal resection (STR) if the tumor is densely adherent to a thinned facial nerve. The objective of this study was to determine if residual volume is associated with progression and whether there is a threshold residual volume that should be pursued during STR to prevent recurrence. A secondary objective of this study was to determine whether facial nerve function at last follow-up was associated with extent of resection (EOR).
    METHODS: Clinical and radiographic data were retrospectively collected from the records of 164 patients with VS who underwent resection. Tumor volumes were measured using Visage, and standard statistical methods were used. The House-Brackmann scale was used to assess changes in facial nerve function before surgery and at last follow-up.
    RESULTS: Sixty-one patients (37%) received gross-total resection (GTR) and 103 (63%) received STR. The median clinical and radiographic follow-ups were 49 and 48 months, respectively. The median residual volume was 0.5 cm3 after STR. Kaplan-Meier actuarial survival analysis revealed a 96.3% 5-year progression-free survival (PFS) rate after GTR, which was greater than that after STR (84.5%, p = 0.03). Recursive partitioning analysis of patients receiving STR revealed a residual volume of 0.60 cm3 as the optimal threshold for recurrence. Patients with residual volume ≥ 0.60 cm3 had a 76.0% 5-year PFS, regardless of adjuvant SRS, which was lower than that for patients undergoing GTR (96.3%) or STR (95.6%) with residual volumes < 0.60 cm3 (p < 0.01). On Cox regression analysis, residual volume ≥ 0.60 cm3 (HR 14.4, p = 0.01) was independently associated with progression, even when accounting for patient age, adjuvant radiosurgery, and preoperative tumor size. In 112 patients with at least 24 months of follow-up after their last treatment, tumor control was achieved in 111 (99.1%) patients at a median last follow-up of 71 months. Worse facial nerve function at the last follow-up was independently associated with prior treatment for VS (adjusted OR 3.7, p = 0.04), but not residual volume cohort or preoperative tumor volume.
    CONCLUSIONS: Residual volume > 0.60 cm3 after VS resection was independently associated with tumor progression, even accounting for adjuvant SRS. These data support maximizing the EOR during VS surgery, even if GTR cannot be safely achieved.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    雪旺氏细胞鞘是良性的来源,缓慢扩张的肿瘤被称为听神经瘤(AN)。AN的诊断和治疗方法必须以患者为中心,考虑到独特的因素和偏好。
    这项研究的目的是研究机器学习和人工智能(AI)如何彻底改变AN管理和诊断程序。
    进行了全面的系统审查,其中包括来自公共数据库的同行评审材料。关于AN的出版物,AI,直到2023年12月的深度学习都被纳入了审查的范围。
    根据我们的分析,用于体积估计的AI模型,分割,肿瘤类型分化,与健康组织的分离已经成功开发。计算生物学的发展意味着人工智能可以有效地用于各个领域,包括生活质量评估,监测,机器人辅助手术,特征提取,影像组学,图像分析,临床决策支持系统,和治疗计划。
    为了更好的诊断和治疗,各种成像方式需要强大的发展,灵活的AI模型,可以处理异构成像数据。随后的调查应该集中于再现发现,以便标准化人工智能方法,这可以改变它们在医疗环境中的用途。
    UNASSIGNED: Schwann cell sheaths are the source of benign, slowly expanding tumours known as acoustic neuromas (AN). The diagnostic and treatment approaches for AN must be patient-centered, taking into account unique factors and preferences.
    UNASSIGNED: The purpose of this study is to investigate how machine learning and artificial intelligence (AI) can revolutionise AN management and diagnostic procedures.
    UNASSIGNED: A thorough systematic review that included peer-reviewed material from public databases was carried out. Publications on AN, AI, and deep learning up until December 2023 were included in the review\'s purview.
    UNASSIGNED: Based on our analysis, AI models for volume estimation, segmentation, tumour type differentiation, and separation from healthy tissues have been developed successfully. Developments in computational biology imply that AI can be used effectively in a variety of fields, including quality of life evaluations, monitoring, robotic-assisted surgery, feature extraction, radiomics, image analysis, clinical decision support systems, and treatment planning.
    UNASSIGNED: For better AN diagnosis and treatment, a variety of imaging modalities require the development of strong, flexible AI models that can handle heterogeneous imaging data. Subsequent investigations ought to concentrate on reproducing findings in order to standardise AI approaches, which could transform their use in medical environments.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:在前庭神经鞘瘤(VS)切除术期间,快速,适当的诊断以及术中听力监测(IM)的使用增加了保留听力的可能性。手术期间,可以使用各种IM方法,即,听觉脑干反应(ABR),经肺心电图(TT-ECochG),和直接的耳蜗神经动作电位。该研究的目的是使用ABR和TT-ECochG评估听力IM的预后价值,以预测术后听力保留,并评估手术各个阶段之间的关系。方法:这项回顾性研究介绍了75例(43例妇女,32人,18-69岁)诊断为VS的患者。结果:术前纯音平均听阈为25.02dBHL,而VS切除后,平均恶化30.03dBHL。根据美国耳鼻咽喉头颈外科学会(AAO-HNS)听力分类,手术前后(前/后),有47/24的病人在听力A级,B中的9/8,2/1在C,和D中的17/42。在言语测听中,在60dBSPL强度下,术前言语辨别得分平均为70.93%,在VS切除后,恶化到38.93%。电生理测试分析表明,在肿瘤切除前,I-VABR间隙为5.06ms,在VS切除后,是6.43ms。结论:该研究揭示了术后听力较差与术中测量的ABR和TT-ECochG变化之间的相关性。听力IM在预测VS患者术后听力方面非常有用,并增加了这些患者术后听力保留的机会。
    Background: Quick and appropriate diagnostics and the use of intraoperative monitoring (IM) of hearing during vestibular schwannoma (VS) resection increase the likelihood of hearing preservation. During surgery, various methods of IM can be used, i.e., auditory brainstem responses (ABRs), transtympanic electrocochleography (TT-ECochG), and direct cochlear nerve action potentials. The aim of the study was to evaluate the prognostic values of IM of hearing using ABR and TT-ECochG in predicting postoperative hearing preservation and to evaluate relationships between them during various stages of surgery. Methods: This retrospective study presents the pre- and postoperative audiological test results and IM of hearing records (TT-ECochG and ABR) in 75 (43 women, 32 men, aged 18-69) patients with diagnosed VS. Results: The preoperative pure tone average hearing threshold was 25.02 dB HL, while after VS resection, it worsened on average by 30.03 dB HL. According to the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) Hearing Classification, before and after (pre/post) surgery, there were 47/24 patients in hearing class A, 9/8 in B, 2/1 in C, and 17/42 in D. In speech audiometry, the average preoperative speech discrimination score at an intensity of 60 dB SPL was 70.93%, and after VS resection, it worsened to 38.93%. The analysis of electrophysiological tests showed that before the tumor removal the I-V ABR interlatencies was 5.06 ms, and after VS resection, it was 6.43 ms. Conclusions: The study revealed correlations between worse postoperative hearing and changes in intraoperatively measured ABR and TT-ECochG. IM of hearing is very useful in predicting postoperative hearing in VS patients and increases the chance of postoperative hearing preservation in these patients.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:听力损失是与前庭神经鞘瘤(VS)相关的常见症状,要么是由于肿瘤对耳蜗神经的影响,要么是由于手术或立体定向放射外科(SRS)等积极治疗。VS的治疗决策基于包括肿瘤大小在内的因素,听力状态,患者症状,和制度偏好。该研究旨在调查VS患者的长期听觉结果,这些患者正在接受具有听力保护意图的积极治疗。
    方法:根据系统评价和荟萃分析指南的首选报告项目进行了系统文献综述,搜索Scopus,Pubmed,和WebofScience数据库从成立到2024年1月。
    方法:符合纳入标准的研究,包括至少5年的随访和评估治疗前后的听力结果,包括在内。使用MetaXL软件计算SRS和显微手术后可用听力的集合患病率估计值。使用非随机干预研究工具中的偏倚风险进行偏倚风险评估。
    结果:九项研究符合纳入标准,356名患者纳入分析。SRS后10年维持可用听力的合并患病率为18.1%(95%置信区间[CI]:1.7%-43.3%),较宽的预测区间表明结果的可变性。显微外科手术表明,保持长期可用的听力的患病率更高,合并估计值为74.5%(95%CI:63.5%-84.1%)。
    结论:本系统综述强调了长期随访在VS治疗中评估听觉结果的重要性。尽管预处理患者选择固有的偏见,用于散发性VS切除的听力保留显微外科手术显示出良好且稳定的长期可用听力。
    OBJECTIVE: Hearing loss is a common symptom associated with vestibular schwannoma (VS), either because of the tumor\'s effects on the cochlear nerve or due to active treatments such as surgery or stereotactic radiosurgery (SRS). Treatment decisions for VS are based on factors including tumor size, hearing status, patient symptoms, and institutional preference. The study aimed to investigate long-term auditory outcomes in VS patients undergoing active treatments with a hearing preservation intent.
    METHODS: A systematic literature review was conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, searching Scopus, Pubmed, and Web of Science databases from inception to January 2024.
    METHODS: Studies meeting inclusion criteria, including a minimum 5-year follow-up and assessment of pre- and posttreatment hearing outcomes, were included. Pooled prevalence estimates for serviceable hearing after SRS and microsurgery were calculated using MetaXL software. Risk of bias assessment was performed with the Risk of Bias in Non-randomized Studies of Interventions tool.
    RESULTS: Nine studies met the inclusion criteria, with 356 patients included for analysis. The pooled prevalence of maintaining serviceable hearing after SRS at 10 years was 18.1% (95% confidence interval [CI]: 1.7%-43.3%), with wide prediction intervals indicating variability in outcomes. Microsurgery demonstrated a higher prevalence of maintaining long-term serviceable hearing, with a pooled estimate of 74.5% (95% CI: 63.5%-84.1%).
    CONCLUSIONS: This systematic review underscores the importance of long-term follow-up in evaluating auditory outcomes in VS treatment. Despite the biases inherent to pretreatment patients selection, hearing preservation microsurgery for sporadic VS removal demonstrated favorable and stable long-term serviceable hearing.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Comparative Study
    这封信评估了最近关于囊性前庭神经鞘瘤(VS)与固体VS相比的治疗研究,重点关注手术(SURGERY)和放射外科(SRS)的临床结果。该研究为这些肿瘤类型之间的差异提供了重要的见解,强调囊性VS带来的挑战,包括快速增长,增强肿瘤周围粘连,术后面神经结局更差。值得注意的是,囊性VS与较高的复发率和较差的术前状态相关。该研究还强调了囊性VS的总切除率(GTR)较低,长期肿瘤控制较差。虽然SRS显示出很高的功能保存率,与固体VS相比,它在确保囊性VS的无复发生存率方面效果较差,建议手术可能更适合获得最佳的长期结果,特别是当安全最大切除是可能的。然而,研究的回顾性设计和有限的样本量,随着缺乏标准化的后续协议,可能会影响调查结果的普遍性。未来的研究应该集中在前瞻性,具有标准化方案的多中心研究,以制定基于证据的治疗囊性VS的指南。创新技术,如先进的成像和微创手术方法,可进一步提高诊断准确性和治疗效果。这项研究强调了管理囊性VS的复杂性以及对定制治疗策略的需求。
    This letter evaluates the recent study on the management of cystic vestibular schwannomas (VS) compared to solid VS, focusing on the clinical outcomes of surgery (SURGERY) and radiosurgery (SRS). The study offers significant insights into the differences between these tumor types, emphasizing the challenges posed by cystic VS, including rapid growth, enhanced peritumoral adhesion, and worse post-operative facial nerve outcomes. Notably, cystic VS are associated with higher recurrence rates and poorer preoperative status. The study also highlights lower gross total resection (GTR) rates and poorer long-term tumor control in cystic VS. While SRS shows high rates of functional preservation, it is less effective in ensuring recurrence-free survival in cystic VS compared to solid VS, suggesting surgery may be preferable for achieving the best long-term outcomes, particularly when safe maximal resection is possible. However, the study\'s retrospective design and limited sample size, along with the lack of standardized follow-up protocols, may impact the generalizability of the findings. Future research should focus on prospective, multicenter studies with standardized protocols to develop evidence-based guidelines for managing cystic VS. Innovative techniques, such as advanced imaging and minimally invasive surgical approaches, may further improve diagnostic accuracy and treatment efficacy. This study underscores the complexities of managing cystic VS and the need for tailored treatment strategies.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目标:在内耳神经鞘瘤(IES)患者中,在过去的十年中,关于人工耳蜗(CI)听力康复的报道有所增加,其中大多数是病例报告或小病例系列。这项研究的目的是考虑到不同国家/地区使用的不同听力学结果指标,系统地回顾IES患者报告的CI听力结果。
    方法:根据系统评价和荟萃分析(PRISMA)指南的首选报告项目,对已发表的文献进行了搜索。我们纳入了IES患者(原发性或继发性从内耳道(IAC)延伸到内耳,散发性或NF2相关)进行耳蜗植入,有或没有肿瘤切除。听力学结果分为“单音节”类别,\"双音节\",“多音节单词或数字”,和“句子”。
    结果:在27份报告中,110例患者和111耳获得了预定义的听力学结果指标。使用CI的单音节单词的平均识别分数为55%(SD:24),双音节单词占61%(SD:36),对于多音节单词和数字,87%(SD:25),和71%(SD:30)的句子。一般来说,多音节单词和数字的结果显示出天花板效应的趋势。表现低于平均水平的可能风险因素是复杂性较高的肿瘤(内耳加IAC/CPA),NF2,无肿瘤切除的CI(“通过肿瘤的CI”),和肿瘤切除后的序贯耳蜗植入(分期手术)。
    结论:在大多数情况下,内耳神经鞘瘤患者的听力损失可以通过CI成功康复,其言语表现高于平均水平。因此,耳蜗植入也是IES患者听力康复的宝贵选择,同时保持了MRI随访的可能性。进一步的研究应该调查表现不佳的可能风险因素。应详细报告听力学测试和结果参数,并理想地进行协调,以更好地比较语言。
    OBJECTIVE: In patients with inner ear schwannomas (IES), reports on hearing rehabilitation with cochlear implants (CI) have increased over the past decade, most of which are case reports or small case series. The aim of this study is to systematically review the reported hearing results with CI in patients with IES considering the different audiologic outcome measures used in different countries.
    METHODS: According to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline, a search of published literature was conducted. We included patients with IES (primary or with secondary extension from the internal auditory canal (IAC) to the inner ear, sporadic or NF2 related) undergoing cochlear implantation with or without tumour removal. The audiological results were divided into the categories \"monosyllables\", \"disyllables\", \"multisyllabic words or numbers\", and \"sentences\".
    RESULTS: Predefined audiological outcome measures were available from 110 patients and 111 ears in 27 reports. The mean recognition scores for monosyllabic words with CI were 55% (SD: 24), for bisyllabic words 61% (SD: 36), for multisyllabic words and numbers 87% (SD: 25), and 71% (SD: 30) for sentences. Results from for multisyllabic words and numbers in general showed a tendency towards a ceiling effect. Possible risk factors for performance below average were higher complexity tumours (inner ear plus IAC/CPA), NF2, CI without tumour removal (\"CI through tumour\"), and sequential cochlear implantation after tumour removal (staged surgery).
    CONCLUSIONS: Hearing loss in patients with inner ear schwannomas can be successfully rehabilitated with CI with above average speech performance in most cases. Cochlear implantation thus represents a valuable option for hearing rehabilitation also in patients with IES while at the same time maintaining the possibility of MRI follow-up. Further studies should investigate possible risk factors for poor performance. Audiological tests and outcome parameters should be reported in detail and ideally be harmonized to allow better comparison between languages.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:谷氨酸化学交换饱和转移(GluCEST)是一种用于检测组织中谷氨酸水平的非侵入性CEST成像技术。我们旨在研究5TGluCEST技术在健康志愿者中的可重复性,并初步探索其在脑肿瘤患者中的潜在临床应用。
    方法:10名志愿者(4名男性,平均年龄29岁)接受了三次5TGluCEST成像扫描。使用单向重复测量方差分析(ANOVA)评估三种成像GluCEST测量的可重复性,广义估计方程,和线性混合模型。28例脑肿瘤患者(10例男性,平均年龄54岁)术前接受一次GluCEST扫描,和t检验用于比较不同脑肿瘤之间GluCEST值的差异。此外,使用受试者工作特征(ROC)曲线评估GluCEST值在区分脑肿瘤中的诊断准确性.
    结果:健康志愿者的GluCEST值的变异系数在一天内小于5%,跨日,和受试者内,低于10%的受试者之间。高级别胶质瘤(HGG)的GluCEST值高于低级别胶质瘤(LGG)(P<0.001)。此外,桥小脑角(CPA)脑膜瘤的GluCEST值高于听神经瘤(P<0.001)。用于区分CPA脑膜瘤和听神经瘤的GluCEST值的曲线下面积(AUC)为0.93。
    结论:5TGluCEST图像在健康大脑中具有很高的可重复性。此外,5TGluCEST技术在区分LGG和HGG以及CPA脑膜瘤和听神经瘤方面具有潜在的临床应用价值。
    OBJECTIVE: Glutamate chemical exchange saturation transfer (GluCEST) is a non-invasive CEST imaging technique for detecting glutamate levels in tissues. We aimed to investigate the reproducibility of the 5T GluCEST technique in healthy volunteers and preliminarily explore its potential clinical application in patients with brain tumors.
    METHODS: Ten volunteers (4 males, mean age 29 years) underwent three 5T GluCEST imaging scans. The reproducibility of the three imaging GluCEST measurements was assessed using one-way repeated measures analysis of variance (ANOVA), generalized estimating equations, and linear mixed models. Twenty-eight patients with brain tumors (10 males, mean age 54 years) underwent a single GluCEST scan preoperatively, and t-tests were used to compare the differences in GluCEST values between different brain tumors. In addition, the diagnostic accuracy of GluCEST values in differentiating brain tumors was assessed using the receiver work characteristics (ROC) curve.
    RESULTS: The coefficients of variation of GluCEST values in healthy volunteers were less than 5% for intra-day, inter-day, and within-subjects and less than 10% for between-subjects. High-grade gliomas (HGG) had higher GluCEST values compared to low-grade gliomas (LGG) (P < 0.001). In addition, cerebellopontine angle (CPA) meningiomas had higher GluCEST values than acoustic neuromas (P < 0.001). The area under the curve (AUC) of the GluCEST value for differentiating CPA meningioma from acoustic neuroma was 0.93.
    CONCLUSIONS: 5T GluCEST images are highly reproducible in healthy brains. In addition, the 5T GluCEST technique has potential clinical applications in differentiating LGG from HGG and CPA meningiomas from acoustic neuromas.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:研究表明,在大前庭神经鞘瘤(VS)中,与显微外科手术切除(SURGERY)相比,放射外科(SRS)在肿瘤控制方面较差。然而,外科手术导致面部功能恶化(FFD)的风险显着增加。这项研究的目的是说明需要治疗/手术(NNO)的有效性,伤害所需数量(NNH),通过比较大VS中的两种治疗方式,以及伤害/帮助的可能性(LHH)。
    方法:这是一个回顾性研究,双中心队列研究。肿瘤大小按汉诺威分类法分类。绝对风险降低和风险增加用于得出治疗有效性的额外估计,即NNO和NNH。然后通过NNH/NNO的商计算LHH,以说明外科手术的风险-收益比。
    结果:接受治疗的49名患者符合纳入标准。SRS中肿瘤复发率明显较高(14%),与外科手术(3%)相比,ARR为11%,NNO为10。同时,手术与FFD的显著风险相关,导致NNH为12。总的来说,计算为1.20的LHH是赞成手术,特别是在40岁以下的患者中(LHH=2.40),囊性VS(LHH=4.33),汉诺威T3a(LHH=1.83)和T3b(LHH=1.80)。
    结论:由于大VS对SRS的响应较差,手术优于肿瘤控制。一次肿瘤复发是可以预防的,当10例患者接受外科手术而不是SRS治疗时。因此,即使考虑到提高FFD,LHH也描绘了大型VS中外科手术的好处。
    OBJECTIVE: It has been shown that in large vestibular schwannomas (VS), radiosurgery (SRS) is inferior with respect to tumor control compared to microsurgical resection (SURGERY). However, SURGERY poses a significantly higher risk of facial-function deterioration (FFD). The aim of this study was to illustrate the effectiveness in terms of number-needed-to-treat/operate (NNO), number-needed-to-harm (NNH), and likelihood-of-harm/help (LHH) by comparing both treatment modalities in large VS.
    METHODS: This was a retrospective, dual-center cohort study. Tumor size was classified by Hannover Classification. Absolute risk reduction and risk increase were used to derive additional estimates of treatment effectiveness, namely NNO and NNH. LHH was then calculated by a quotient of NNH/NNO to illustrate the risk-benefit-ratio of SURGERY.
    RESULTS: Four hundred and forty-nine patients treated met the inclusion criteria. The incidence of tumor recurrence was significantly higher in SRS (14%), compared to SURGERY (3%) resulting in ARR of 11% and NNO of 10. At the same time, SURGERY was related to a significant risk of FFD resulting in an NNH of 12. Overall, the LHH calculated at 1.20 was favored SURGERY, especially in patients under the age of 40 years (LHH = 2.40), cystic VS (LHH = 4.33), and Hannover T3a (LHH = 1.83) and T3b (LHH = 1.80).
    CONCLUSIONS: Due to a poorer response of large VS to SRS, SURGERY is superior with respect to tumor control. One tumor recurrence can be prevented, when 10 patients are treated by SURGERY instead of SRS. Thus, LHH portrays the benefit of SURGERY in large VS even when taking raised FFD into account.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号